Evidence map›Paper›PMID 25996607›Full record

ArticlePloS one2015

Thymoquinone Inhibits Escherichia coli ATP Synthase and Cell Growth.

Zulfiqar Ahmad, Thomas F Laughlin, Ismail O Kady

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. GSH Protects theMolecules (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Safranal and its analogs inhibit Escherichia coli ATP synthase and cell growth.International journal of biological macromolecules · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Zulfiqar AhmadDepartment of Biochemistry, Kirksville College of Osteopathic Medicine, A T Still University of Health Sciences, Kirksville, MO, 63501, United States of America.
Thomas F LaughlinDepartment of Biochemistry, Kirksville College of Osteopathic Medicine, A T Still University of Health Sciences, Kirksville, MO, 63501, United States of America.
Ismail O KadyDepartment of Chemistry, East Tennessee State University, Johnson City, TN, 37614, United States of America.

Funding

Molecular Modulation of Catalytic Sites of Escherichia coli F1Fo ATP SynthaseR15GM085771 · NIGMS · EAST TENNESSEE STATE UNIVERSITY · PI AHMAD, ZULFIQAR · 2009 to 2009
$209k
NIGMS NIH HHS GM085771NIGMS NIH HHS R15 GM085771
6 · The paper itself

Abstract

We examined the thymoquinone induced inhibition of purified F1 or membrane bound F1FO E. coli ATP synthase. Both purified F1 and membrane bound F1FO were completely inhibited by thymoquinone with no residual ATPase activity. The process of inhibition was fully reversible and identical in both membrane bound F1Fo and purified F1 preparations. Moreover, thymoquinone induced inhibition of ATP synthase expressing wild-type E. coli cell growth and non-inhibition of ATPase gene deleted null control cells demonstrates that ATP synthase is a molecular target for thymoquinone. This also links the beneficial dietary based antimicrobial and anticancer effects of thymoquinone to its inhibitory action on ATP synthase.

Indexed as

ATP Synthetase ComplexesBenzoquinonesCulture MediaDose-Response Relationship, DrugEnzyme ActivationEnzyme InhibitorsEscherichia coliATP Synthetase ComplexesBenzoquinonesCulture MediaEnzyme Inhibitorsthymoquinone

Identifiers

PMID25996607
PMCPMC4440651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.